Akoya Biosciences, Inc. (AKYA) Financial Analysis & Valuation | Quarter Chart
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics sys... more
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focu... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $64.44M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | US | CEO | Brian McKelligon |
| IPO Date | 2021-04-16 | CAGR | 14.1% |
| Employees | 205 | Website | www.akoyabio.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
AKYA chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $132.40M | P/E | -1.34 | Forward P/E | — | PEG | — |
| P/S | 1.7 | P/B | -10.88 | P/CF | -6.28 | P/FCF | -5.63 |
| Sales | $79.96M | Sales 1Y | -14.55% | Sales 3Y | 34.17% | Sales 5Y | — |
| EPS | $-0.96 | EPS 1Y | — | EPS 3Y | — | EPS 5Y | — |
| Sales QoQ | -22.04% | EPS QoQ | 88.24% | Sales QoQ Avg | -0.29% | EPS QoQ Avg | 0.8% |
| Gross Margin | 63.87% | Operating Margin | -50.35% | Profit Margin | -62.79% | ROCE | -418.74% |
| ROA | -21% | ROE | -2796% | Altman Z Score | -4.24 | Piotroski Score | 4 |
| Current Ratio | 0.61 | Quick Ratio | 0.4 | Cash Ratio | 0.19 | Op. CF Ratio | -0.07 |
| Debt/Equity | -14.22 | Debt/Assets | 0.74 | Lt Debt/Equity | -0.68 | Lt Debt/Cap. | — |
| Intrst Cov. | -3.77 | Inventory Turnover | 0.6 | Asset Turnover | 0.34 | Receivables Turnover | 3.23 |
| Enterprise Value | $132.40M | P/E Ratio | -1.34 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 1.7 | P/B Ratio | -10.88 |
| P/CF Ratio | -6.28 | P/FCF Ratio | -5.63 |
| EPS | $-0.96 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | -14.55% | Gross Margin | 63.87% |
| Operating Margin | -50.35% | Profit Margin | -62.79% |
| ROE | -2796% | ROA | -21% |
| ROCE | -418.74% | Current Ratio | 0.61 |
| Quick Ratio | 0.4 | Cash Ratio | 0.19 |
| Debt/Equity | -14.22 | Interest Coverage | -3.77 |
| Altman Z Score | -4.24 | Piotroski Score | 4 |
Akoya Biosciences, Inc. (AKYA) valuation & financials
Akoya Biosciences, Inc. (AKYA) has a market capitalization of $64.44M and trades at a price-to-earnings ratio of -1.3. It operates in the Healthcare sector (Medical - Instruments & Supplies).
Akoya Biosciences, Inc.'s revenue grew -14.5% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)